It is a pharma private limited company based in Delhi, Delhi, India, established in 2014.
2014 | Delhi, Delhi, India | ActiveSarva Pharmaceuticals Private Limited, a active private limited company, was established on 24 November 2014 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100DL2014PTC273464. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Hem Lata Chaubey (Director), Jai Prakash Chaubey (Director), Prashant Kumar Chaubey (Director). It holds ₹2.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No:-993-994, Vegas Mall,Plot No.6, Sector-14, Dwarka, New Delhi,, Delhi, Delhi, 110075.
U24100DL2014PTC273464
273464
24 November 2014
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Sarva Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hem Lata Chaubey | Director | 24 Nov 2014 | Current |
| Jai Prakash Chaubey | Director | 24 Nov 2014 | Current |
| Prashant Kumar Chaubey | Director | 06 Oct 2021 | Current |
| Nishant Chaubey | Director | 06 Oct 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sarva Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.3% increase. The company also saw a substantial improvement in profitability, with a 107.44% increase in profit. The company's net worth moved up by a moderate rise of 2.77%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sarva Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹20,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Feb 2024 | Others | ₹2.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sarva Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sarva Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarva Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 20.00 M registered on 20 Feb 2024 with Charge ID 100883170 was modified on 03 Apr 2025. was recorded as a recent event.
The activity Sarva Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Sarva Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity A charge with Others amounted to Rs. 20.00 M with Charge ID 100883170 was registered on 20 Feb 2024. was completed.
The activity Prashant Kumar Chaubey was appointed as a Director was appointed as a Director on 06 Oct 2021 & has been associated with this company since 4 years 2 months . was completed.
Nishant Chaubey was appointed as a Director was appointed as a Director on 06 Oct 2021 & has been associated with this company since 4 years 2 months . was recorded as a recent event.
The CIN of Sarva Pharmaceuticals Private Limited is U24100DL2014PTC273464.
Sarva Pharmaceuticals Private Limited is headquartered at Unit No:-993-994, Vegas Mall,Plot No.6, Sector-14, Dwarka, New Delhi,, Delhi, Delhi, 110075.
Sarva Pharmaceuticals Private Limited was incorporated on 24 November 2014.
The current directors of Sarva Pharmaceuticals Private Limited are
The primary industry of Sarva Pharmaceuticals Private Limited is Manufacturing.
Sarva Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sarva Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Sarva Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX